One of the most important aspects for any drug development program is proper interaction with regulatory authorities like the US Food and Drug Administration (FDA). Clear communication with the FDA can greatly increase the chances of getting your drug approved.
In this toolkit, you will find five essential resources to improve your communication with the FDA. You will benefit from first-hand experience and advice from Nuventra consultants Gene Williams and Brian Furmanski, who spent a combined 23 years as clinical pharmacology reviewers at the FDA.
Request your Communicating with the FDA Toolkit: